Scarica l'app Stockscreener
7.86
1.95%
0.15
Dopo l'orario di chiusura:
7.96
0.10
+1.27%
Precedente Chiudi:
$7.71
Aprire:
$7.87
Volume 24 ore:
764.77K
Relative Volume:
0.93
Capitalizzazione di mercato:
$770.92M
Reddito:
-
Utile/perdita netta:
$-209.96M
Rapporto P/E:
-2.4873
EPS:
-3.16
Flusso di cassa netto:
$-176.27M
1 W Prestazione:
-21.48%
1M Prestazione:
+6.94%
6M Prestazione:
-35.52%
1 anno Prestazione:
+22.62%
Intervallo 1D:
$7.67
$8.28
Intervallo di 1 settimana:
$6.93
$9.96
Portata 52W:
$4.92
$17.00
Replimune Group Inc Stock (REPL) Company Profile
Nome
Replimune Group Inc
Settore
Industria
Telefono
(781) 222-9600
Indirizzo
500 UNICORN PARK, WOBURN, MA
Confronta REPL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
REPL
Replimune Group Inc
|
7.86 | 770.92M | 0 | -209.96M | -176.27M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2023-04-17 | Ripresa | Piper Sandler | Overweight |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2020-11-17 | Iniziato | BTIG Research | Buy |
| 2020-11-02 | Iniziato | Jefferies | Buy |
| 2020-10-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2019-09-04 | Iniziato | ROTH Capital | Buy |
| 2019-07-23 | Iniziato | Chardan Capital Markets | Buy |
| 2019-07-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-07-08 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-25 | Iniziato | Wedbush | Outperform |
| 2019-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-08-14 | Iniziato | JP Morgan | Overweight |
| 2018-08-14 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Replimune Group Inc Borsa (REPL) Ultime notizie
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Tower Research Capital LLC TRC Acquires 5,922 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REPL Stock News - GuruFocus
Keep Talking: US FDA’s Beleaguered Biologics Center Remains Vital To Regenerative Medicine - insights.citeline.com
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $19.43 - Defense World
Replimune Group (REPL) Projected to Post Earnings on Thursday - Defense World
MetLife Investment Management LLC Raises Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
(REPL) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Sells 92,952 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Perhaps timely catching Replimune Group Inc (REPL) would be a good idea - Sete News
A stock that deserves closer examination: Replimune Group Inc (REPL) - uspostnews.com
XTX Topco Ltd Purchases New Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Wells Fargo & Company MN - Defense World
Potential Price Increase for Replimune Group Inc (REPL) After Recent Insider Activity - knoxdaily.com
Market Insights: Replimune Group Inc (REPL)’s Notable Gain of 2.43, Closing at 9.27 - DWinneX
Legal & General Group Plc Has $719,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For Melanoma (NASDAQ:REPL) - Seeking Alpha
Are Replimune Group Inc’shares a good deal? - uspostnews.com
Market Momentum Report: Replimune Group Inc (REPL)’s Positive Close at 8.83 - DWinneX
The Growing Financial Burden on Patients and Caregivers in Cancer Care - Targeted Oncology
A Detailed Analysis Of Replimune Group Inc (REPL) - Marketing Sentinel
Could The Upcoming FDA Decision Ignite Investor Confidence In REPL? - RTTNews
Replimune Group Inc (REPL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Has $5.89 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Alliancebernstein L.P. Sells 48,397 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Vanguard Group Inc. Has $43.55 Million Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA - MSN
Sei Investments Co. Purchases New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune stock target raised to $22 at H.C. Wainwright - MSN
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN
Is Replimune Group (NASDAQ:REPL) A Risky Investment? - simplywall.st
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World
KLP Kapitalforvaltning AS Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Corebridge Financial Inc. Reduces Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Stake Lifted by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Takes $189,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Trading Down 7.6%What's Next? - MarketBeat
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy - The Manila Times
SynOx Therapeutics Announces Board Chair Transition to - GlobeNewswire
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Swiss National Bank - Defense World
Charles Schwab Investment Management Inc. Has $6.16 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Victory Capital Management Inc. Purchases Shares of 44,880 Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Bank of New York Mellon Corp Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Holdings Cut by AlphaQuest LLC - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Average Price Target from Analysts - Defense World
Arizona State Retirement System Invests $156,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Financial Metrics Check: Replimune Group Inc (REPL)’s Ratios for Trailing Twelve Months - The Dwinnex
(REPL) Trading Signals - news.stocktradersdaily.com
Replimune Group Inc Azioni (REPL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):